Evidence map›Paper›PMID 25597940›Full record

ArticleVaccine2015

Expansion of syndromic vaccine preventable disease surveillance to include bacterial meningitis and Japanese encephalitis: evaluation of adapting polio and measles laboratory networks in Bangladesh, China and India, 2007-2008.

Kathleen F Cavallaro, Hardeep S Sandhu, Terri B Hyde, Barbara W Johnson, Marc Fischer, Leonard W Mayer, Thomas A Clark, Mark A Pallansch, Zundong Yin, Shuyan Zuo and 6 more

Abstract read
In one paragraph

Article in Vaccine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 5 countries.

Kathleen F CavallaroGlobal Immunization Division, United States Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: KCavallaro@cdc.gov.
Hardeep S SandhuGlobal Immunization Division, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Terri B HydeGlobal Immunization Division, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Barbara W JohnsonDivision of Vector-Borne Diseases, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Marc FischerDivision of Vector-Borne Diseases, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Leonard W MayerDivision of Bacterial Diseases, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Thomas A ClarkDivision of Bacterial Diseases, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Mark A PallanschDivision of Viral Diseases, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
Zundong YinNational Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Shuyan ZuoWorld Health Organization, Beijing, People's Republic of China.
Stephen C HadlerWorld Health Organization, Beijing, People's Republic of China.
Serguey DiorditsaWorld Health Organization, Dhaka, Bangladesh.
A S M Mainul HasanWorld Health Organization, Male, Maldives.
Anindya S BoseNational Polio Surveillance Project, World Health Organization, New Delhi, India.
Vance DietzGlobal Immunization Division, United States Centers for Disease Control and Prevention, Atlanta, GA, USA.
AMES Study Group
Centers for Disease Control and Prevention · USChinese Center For Disease Control and Prevention · CNMaldives National University · MVWorld Health Organization - India · INWorld University of Bangladesh · BD

Funding

Intramural CDC HHS CC999999World Health Organization 001
6 · The paper itself

Abstract

backgroundSurveillance for acute flaccid paralysis with laboratory confirmation has been a key strategy in the global polio eradication initiative, and the laboratory platform established for polio testing has been expanded in many countries to include surveillance for cases of febrile rash illness to identify measles and rubella cases. Vaccine-preventable disease surveillance is essential to detect outbreaks, define disease burden, guide vaccination strategies and assess immunization impact. Vaccines now exist to prevent Japanese encephalitis (JE) and some etiologies of bacterial meningitis.

methodsWe evaluated the feasibility of expanding polio-measles surveillance and laboratory networks to detect bacterial meningitis and JE, using surveillance for acute meningitis-encephalitis syndrome in Bangladesh and China and acute encephalitis syndrome in India. We developed nine syndromic surveillance performance indicators based on international surveillance guidelines and calculated scores using supervisory visit reports, annual reports, and case-based surveillance data.

resultsScores, variable by country and targeted disease, were highest for the presence of national guidelines, sustainability, training, availability of JE laboratory resources, and effectiveness of using polio-measles networks for JE surveillance. Scores for effectiveness of building on polio-measles networks for bacterial meningitis surveillance and specimen referral were the lowest, because of differences in specimens and techniques.

conclusionsPolio-measles surveillance and laboratory networks provided useful infrastructure for establishing syndromic surveillance and building capacity for JE diagnosis, but were less applicable for bacterial meningitis. Laboratory-supported surveillance for vaccine-preventable bacterial diseases will require substantial technical and financial support to enhance local diagnostic capacity.

Indexed as

Epidemiological MonitoringSentinel SurveillanceBangladeshChinaEncephalitisHealth Services ResearchHumansIndiaMeningitisJapanese encephalitisMeningitisSurveillanceVaccine preventable diseasesVPD

Identifiers

PMID25597940
PMCPMC4830482
OpenAlexW2002263960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.